Skip to main content

Elchrom, Biotium Partner on Pre-cast Gels for HLA Typing

NEW YORK (GenomeWeb News) – Biotium's GelRed will be incorporated into Elchrom Scientific's pre-cast gels for HLA typing and sold globally as part of an agreement announced by the companies today.

Switzerland-based Elchrom develops materials and methods for separating nucleic acids. The HLA Ready-to-Use Gels with GelRed are the first of its kind to be stained with GelRed and offers eight-channel capability for up to 96 sample testing simultaneously within seven minutes, it said.

"The new HLA Ready-to-use Gels will provide customers with much needed speed, simplicity, reproducible results and significantly improved convenience, thus saving valuable time from tedious old-fashioned gel pouring and casting," Elechrom CEO Zisi Fotev said in a statement.

Terms of the deal were not disclosed.

Biotium is based in Hayward, Calif., and provides fluorescence detection technology and products.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.